Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialEurope PMC

Efficacy of low-level laser therapy for body contouring and spot fat reduction

Caruso-Davis MK., Guillot TS., Podichetty VK., Mashtalir N., Dhurandhar NV., Dubuisson O.

Randomized Controlled Trial, published in Obes Surg (2011) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Obes Surg (2011)
Reported sample size
—
Source database
Europe PMC
PMID
20393809
PMCID
PMC5225499
DOI
10.1007/s11695-010-0126-y
Citations
73

Abstract (original English)

Background Low-level laser therapy (LLLT) is commonly used in medical applications, but scientific studies of its efficacy and the mechanism by which it causes loss of fat from fat cells for body contouring are lacking. This study examined the effectiveness and mechanism by which 635–680 nm LLLT acts as a non-invasive body contouring intervention method. Methods Forty healthy men and women ages 18–65 years with a BMI Results Data were analyzed for those with body weight fluctuations within 1.5 kg during 4 weeks of the study. Each treatment gave a 0.4–0.5 cm loss in waist girth.Cumulative girth loss after 4 weeks was −2.15 cm (−0.78 ± 2.82 vs. 1.35 ± 2.64 cm for the control group,p Conclusions LLLT achieved safe and significant girth loss sustained over repeated treatments and cumulative over 4 weeks of eight treatments. The girth loss from the waist gave clinically and statistically significant cosmetic improvement.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AdipocytesHumansTriglyceridesCosmetic TechniquesDouble-Blind MethodLipolysisAdolescentAdultAgedMiddle Aged

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.